A new Alcohol and Tobacco Tax and Trade Bureau (TTB) ruling released October 13 allows a gluten-free label on spirits distilled from gluten-containing grains.
Continue ReadingOne of our most important research investments over the last several years has been in iCureCeliac®, the nation’s celiac disease patient registry. This month, researchers published three important studies that used iCureCeliac® as the data source.
Continue ReadingA study led by Columbia University and Celiac Disease Foundation researchers examined probiotic use among celiac disease patients and was an Outstanding Poster Presenter recipient at the 2020 ACG Annual Scientific Meeting.
Continue ReadingNew research from Columbia University revealed differences in the antibodies present, adding evidence that NCGS involves a different kind of inflammation in the gut in response to gluten.
Continue ReadingThe Celiac Disease Foundation is proud to partner with Mediaplanet for their Morning Nutrition campaign.
Continue ReadingA new study from Columbia University is the first to follow the trail for many years and show that people diagnosed with celiac disease in childhood are more likely to experience psychological conditions well into adulthood.
Continue ReadingSecuring public and private health insurance coverage of Medical Nutrition Therapy (MNT) for celiac disease patients has been a long-time priority of the Celiac Disease Foundation.
Continue ReadingThe Celiac Disease Foundation through the generosity of Proud Sponsor Schar is providing reimbursement grants to dietitians who complete all five COT modules.
Continue ReadingDietitians and doctors say a new federal bill to extend Medicare coverage for nutritional therapy provided by a registered dietitian would provide better healthcare for Americans with celiac disease.
Continue ReadingDr. Samuel Gee was the first researcher to recognize that the symptoms of celiac disease could be treated through diet. Today, we celebrate Celiac Disease Awareness Day on Dr. Gee's birthday and remember how far we've come in celiac disease knowledge and research, while recognizing there is still a critical need for treatments and a cure.
Continue ReadingLast month, the Celiac Disease Foundation had the privilege of sponsoring the 2024 International Celiac Disease Symposium in Sheffield, UK. As the first patient advocate invited to chair and present on a scientific panel, CEO Marilyn Geller co-chaired the End Points in Clinical Trials session with Dr. Francisco Leon, CEO...